SLFN11
Basic information
Region (hg38): 17:35350305-35373701
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (122 variants)
- not_provided (4 variants)
- Moyamoya_angiopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLFN11 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001376007.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 104 | 18 | 125 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 1 | 104 | 19 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLFN11 | protein_coding | protein_coding | ENST00000394566 | 4 | 23397 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.22e-19 | 0.00110 | 125713 | 0 | 32 | 125745 | 0.000127 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.327 | 480 | 460 | 1.04 | 0.0000244 | 5894 |
| Missense in Polyphen | 122 | 124.06 | 0.98336 | 1781 | ||
| Synonymous | -1.63 | 199 | 172 | 1.16 | 0.00000924 | 1744 |
| Loss of Function | -0.566 | 26 | 23.1 | 1.13 | 0.00000112 | 318 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000285 | 0.000278 |
| Ashkenazi Jewish | 0.000108 | 0.0000992 |
| East Asian | 0.000290 | 0.000272 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000144 | 0.000141 |
| Middle Eastern | 0.000290 | 0.000272 |
| South Asian | 0.0000693 | 0.0000653 |
| Other | 0.000169 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibitor of DNA replication that promotes cell death in response to DNA damage (PubMed:22927417, PubMed:26658330, PubMed:29395061). Acts as a guardian of the genome by killing cells with defective replication (PubMed:29395061). Persistently blocks stressed replication forks by opening chromatin across replication initiation sites at stressed replication forks, possibly leading to unwind DNA ahead of the MCM helicase and block fork progression, ultimately leading to cell death (PubMed:29395061). Acts independently of ATR (PubMed:29395061). Also acts as an interferon (IFN)-induced antiviral protein which acts as an inhibitor of retrovirus protein synthesis (PubMed:23000900). Specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1) by acting as a specific inhibitor of the synthesis of retroviruses encoded proteins in a codon-usage-dependent manner (PubMed:23000900). Binds to tRNAs and exploits the unique viral codon bias towards A/T nucleotides (PubMed:23000900). The exact inhibition mechanism is unclear: may either sequester tRNAs, prevent their maturation via post-transcriptional processing or may accelerate their deacylation (PubMed:23000900). Does not inhibit reverse transcription, integration or production and nuclear export of viral RNA (PubMed:23000900). {ECO:0000269|PubMed:22927417, ECO:0000269|PubMed:23000900, ECO:0000269|PubMed:26658330, ECO:0000269|PubMed:29395061}.;
Intolerance Scores
- loftool
- 0.316
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.71
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- N
- hipred_score
- 0.148
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.468
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cellular response to DNA damage stimulus;negative regulation of DNA replication;positive regulation of cell death;replication fork arrest;defense response to virus;negative regulation of G1/S transition of mitotic cell cycle
- Cellular component
- nucleus;nucleoplasm;cytosol;aggresome;site of DNA damage
- Molecular function
- tRNA binding;helicase activity;protein binding;ATP binding;ATPase activity